The NHS Long Term Plan committed to accelerate the uptake of selected innovative medical devices, diagnostics and digital products to patients faster, by developing the MedTech Funding Mandate (MTFM) policy. The policy launched on the 1st April 2021.
The AHSN Network, including Wessex AHSN, supports the implementation of the technologies named on the MTFM, working with clinical teams locally and technology suppliers.
The policy aims to:
i) direct the NHS on which MedTech innovations are effective and likely to give savings on investment;
ii) ensure the NHS has a sustainable approach to overcoming the financial barriers to adopting medical devices, diagnostics and digital products.
You can access the full MTFM policy at the NHS England/Improvement MTFM page.
For the 2021/22 year, the supported technologies include;
Technologies covered by the MedTech Funding Mandate in 2022/23
The MedTech Funding Mandate (MTFM) will add further technologies to it's remit annually, providing they are effective, cost saving within three years of implementation and are affordable to the NHS (See the NHS England/Improvement MTFM webpages for further details on eligibility criteria).
For 2022/23, the technologies currently meeting the criteria for inclusion in the MTFM 2022/23 policy are categorised into two themes, described below. The final list of technologies to be included in the MTFM 2022/23 policy guidance to be published in early 2022.
You can read about the specific technologies on the MTFM webpage.
To find out more about this work, please contact us